Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 126

Related Citations for PubMed (Select 23799549)

1.

The effect of MAPK inhibitors and ROS modulators on cell growth and death of H₂O₂-treated HeLa cells.

Park WH.

Mol Med Rep. 2013 Aug;8(2):557-64. doi: 10.3892/mmr.2013.1551. Epub 2013 Jun 25.

PMID:
23799549
2.
4.

The enhancement of propyl gallate-induced HeLa cell death by MAPK inhibitors is accompanied by increasing ROS levels.

You BR, Park WH.

Mol Biol Rep. 2011 Apr;38(4):2349-58. doi: 10.1007/s11033-010-0368-8. Epub 2010 Nov 17.

PMID:
21082265
5.
7.

MAPK inhibitors augment gallic acid-induced A549 lung cancer cell death through the enhancement of glutathione depletion.

Park WH, Kim SH.

Oncol Rep. 2013 Jul;30(1):513-9. doi: 10.3892/or.2013.2447. Epub 2013 May 9.

PMID:
23660987
8.

MAPK inhibitors and siRNAs differentially affect cell death and ROS levels in arsenic trioxide-treated human pulmonary fibroblast cells.

Park WH.

Oncol Rep. 2012 May;27(5):1611-8. doi: 10.3892/or.2012.1661. Epub 2012 Jan 27.

PMID:
22293863
9.

The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels.

Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH.

Anticancer Res. 2009 Oct;29(10):3837-44.

10.

The effects of MAPK inhibitors on a proteasome inhibitor, MG132-induced HeLa cell death in relation to reactive oxygen species and glutathione.

Han YH, Park WH.

Toxicol Lett. 2010 Feb 1;192(2):134-40. doi: 10.1016/j.toxlet.2009.10.015. Epub 2009 Oct 23.

PMID:
19854251
11.

MG132, a proteasome inhibitor, induces human pulmonary fibroblast cell death via increasing ROS levels and GSH depletion.

Park WH, Kim SH.

Oncol Rep. 2012 Apr;27(4):1284-91. doi: 10.3892/or.2012.1642. Epub 2012 Jan 19.

12.

MG132, a proteasome inhibitor-induced calf pulmonary arterial endothelial cell growth and death, are changed by MAPK inhibitors.

You BR, Park WH.

Drug Chem Toxicol. 2011 Jan;34(1):45-52. doi: 10.3109/01480545.2010.494663. Epub 2010 Oct 18.

PMID:
20954830
13.
14.

MAPK inhibitors differentially affect gallic acid-induced human pulmonary fibroblast cell growth inhibition.

Park WH.

Mol Med Rep. 2011 Jan-Feb;4(1):193-04. doi: 10.3892/mmr.2010.361. Epub 2010 Sep 10.

PMID:
21461585
15.

The effects of MAPK inhibitors on pyrogallol-treated Calu-6 lung cancer cells in relation to cell growth, reactive oxygen species and glutathione.

Han YH, Moon HJ, You BR, Park WH.

Food Chem Toxicol. 2010 Jan;48(1):271-6. doi: 10.1016/j.fct.2009.10.010. Epub 2009 Oct 13.

PMID:
19833163
16.

Anti-apoptotic effect of caspase inhibitors on H₂O₂-treated HeLa cells through early suppression of its oxidative stress.

Park WH.

Oncol Rep. 2014 May;31(5):2413-21. doi: 10.3892/or.2014.3084. Epub 2014 Mar 12.

PMID:
24627148
17.

p38 inhibitor intensified cell death in antimycin A-treated As4.1 juxtaglomerular cells via the enhancement of GSH depletion.

Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH.

Anticancer Res. 2009 Nov;29(11):4423-31.

18.

The enhancement of propyl gallate-induced apoptosis in HeLa cells by a proteasome inhibitor MG132.

You BR, Park WH.

Oncol Rep. 2011 Mar;25(3):871-7. doi: 10.3892/or.2010.1121. Epub 2010 Dec 24.

PMID:
21186403
19.

Pyrogallol-induced As4.1 juxtaglomerular cell death is attenuated by MAPK inhibitors via preventing GSH depletion.

Han YH, Park WH.

Arch Toxicol. 2010 Aug;84(8):631-40. doi: 10.1007/s00204-010-0526-8. Epub 2010 Feb 27.

PMID:
20191265
20.

JNK and p38 inhibitors increase and decrease apoptosis, respectively, in pyrogallol-treated calf pulmonary arterial endothelial cells.

Han YH, Moon HJ, You BR, Kim SZ, Kim SH, Park WH.

Int J Mol Med. 2009 Nov;24(5):717-22.

PMID:
19787207
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk